SUMMARY Technetium labelled, negatively charged, unilamellar liposomes were given by intravenous injection to patients with rheumatoid arthritis and the joints scanned 20-22 hours later. Positive scintigraphy was obtained in all six patients with active disease, and, with the exception of the small interphalangeal joints, all clinically involved joints could be visualised. 
These particles are taken up by the cells of the reticuloendothelial system and after intravenous injection are found mainly in the Kupffer cells of the liver and the macrophages of the bone marrow and spleen. Their distribution in vivo can be determined by labelling the liposomes with gamma emitting radionuclides such as technetium.
The inflamed synovial tissue of patients with rheumatoid arthritis is rich in phagocytic cells. This preliminary study was undertaken to determine whether labelled liposomes could be used to identify inflamed joints in patients with rheumatoid arthritis.
Patients and methods
Two control subjects and eight patients with rheumatoid arthritis were studied. The patients fulfilled the criteria of the American Rheumatism Association for definite/classical rheumatoid arthritis.3 Six patients with rheumatoid arthritis had active disease with synovitis and were receiving treatment with either Myocrisin or penicillamine. The two patients with inactive disease were chosen because they had No side effects were observed in any of the patients or control subjects who received the liposome preparation.
Even though the scans obtained at four hours showed accumulation of radioactivity within the liver and spleen there was very little accumulation within synovial tissue. A lateral view of the knee joint is shown in Fig. 1 , and it can be seen that most of the radioactivity was located within the blood vessels and the bone marrow at the lower end of the femur. At 20 hours bone marrow uptake was still visible, there was increased activity in synovial tissue, but the blood vessels were no longer identifiable (Fig. lb) .
Radioactivity was detectable in synovial fluid 10 minutes after the intravenous injection of liposomes (synovial fluid radioactivity was 0.7% of blood radioactivity), and during the subsequent 90 minutes the activity rose to 13% of that present in the peripheral blood. The and eluted in the void volume fractions after Sephadex G75 gel filtration of both synovial fluid and plasma.
Aspiration of 40 ml of synovial fluid from the knee joint made little difference to the radioactive counts obtained by scintigraphy at 20 hours. The pre-and postaspiration counts over the knee joint did not change significantly (15-3 cps and 14-9 cps respectively), while the 40 ml of synovial fluid yielded only 1-3 cps. Two scintigraphic counts obtained from the non-aspirated knee were 12A4 cps and 12-3 cps.
There were clear differences between normal individuals (Fig. lc) and patients with rheumatoid arthritis (Fig. ld) . Focal accumulations of radioactivity in the metacarpophalangeal joints and in the wrists of patients with rheumatoid synovitis were readily seen. Although clinical involvement of the proximal interphalangeal joints was present, it often proved difficult to show increased accumulation of radioactivity within these small joints. Other inflamed joints could, however, be easily identified, and increased accumulation of radioactivity in the shoulder and elbow joints is shown in Figs 2a (Fig. 2d) , which showed the extent of the bone destruction produced by the rheumatoid disease process. ' 7 Enhanced uptake of liposomes in tumour tissue has been shown to occur in experimental animals,4 though tumour localisation has not been satisfactorily achieved in man using similar techniques.2 6 The successful demonstration of uptake in rheumatoid synovium is probably due to two factors. We used small liposomes which were removed slowly from the circulation, could cross the capillary barrier in inflamed tissue, and gain access to the cells in the synovial tissue. The second factor reflects the presence in synovial tissue of 'reticuloendothelial phagocytes', which serve as natural targets for the injected liposomes. We presume that the accumulation of radioactivity in the synovial tissue represents the endocytosis of liposomes by these cells, though we do not know which cell type is responsible for the uptake. Since indium labelled neutrophils have been shown to accumulate in the knee joints of patients with rheumatoid arthritis' we are unable to exclude the possibility that some of the liposome localisation may be due to the migration into the joints of polymorphs which have endocytosed these particles in the circulation.
Although our results are consistent with the idea that positive scintigraphs represent endocytosis of radiolabelled liposomes by phagocytic cells, some caution is required in interpreting our findings. The behaviour of liposomes after intravenous injection is complex and it is known that their properties can be substantially modified after their interaction with a number of plasma proteins. 
